Funding for this research was provided by:
Received: 30 August 2019
Accepted: 25 August 2020
First Online: 26 October 2020
Compliance with Ethical Standards
: The authors declare that they do not have a conflict of interest.
: Dr. Coronado: From November 2014 to August 2015, Dr. Coronado served as a co-investigator on an industry-funded study to evaluate patient adherence to an experimental blood test for colorectal cancer. The study was funded by EpiGenomics. From September 2017 to June 2018, Dr. Coronado served as the Principal Investigator on an industry-funded study to compare the clinical performance of an experimental FIT to an FDA-approved FIT. This study is funded by Quidel Corporation. Dr. Coronado has served as a scientific advisor for Exact Sciences and Guardant Health. All other authors declare no conflicts of interest.
: The study was approved by the Institutional Review Board of Kaiser Permanente Northwest on December 6, 2013. The project received a waiver of informed consent; however, all interview participants provided verbal assent. All staff have been trained in ethical conduct of human subject research.
: Not applicable.
: The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The study sponsor had no role in study design; collection, analysis, and interpretation of data; writing the report; or the decision to submit the report for publication.